Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptus" or the "Company"), a clinical stage biotechnology company dedicated to pioneering innovative cancer and ...

Nine Utrecht researchers to receive NWO grants for groundbreaking and high-risk research ...

Immunotherapy uses a person's own immune system to fight cancer. Immune checkpoint inhibitors are one class of immunotherapy ...

Considered to be one of the greatest revolutions in cancer treatment, immunotherapy enhances the immune system's ability to ...

challenging the rejection of its application to begin Phase I human trials of its cancer immunotherapy drug, Per-C-Vax, for patients recently diagnosed with solid organ cancers. A bench of Chief ...

Novartis and Bristol-Myers Squibb have made a move to collaborate in one of the hottest areas in pharma today: immunotherapy treatments for non-small cell lung cancer (NSCLC). Lung cancer is the ...

Bristol-Myers Squibb has signed an agreement worth $475 million to develop a new form of cancer immunotherapy drug with US biotech Dragonfly Therapeutics. BMS is best known as an early pioneer of ...

May 8, 2025 — Researchers have completed a comprehensive analysis of cancer statistics for different age groups in the United States and found that from 2010 through 2019, the incidence of 14 ...

Despite the efforts of the scientific community, cancer is still a leading cause of death worldwide. Immunotherapy, a ground-breaking strategy for cancer ...